Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel C Lynn

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cell|October 30, 2020
Strength in Numbers: Identifying Neoantigen Targets for Cancer ImmunotherapyRigel J Kishton, Rachel C Lynn, Nicholas P Restifo
Journal of Virology|January 27, 2012
Tissue exit: a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza a virus-infected lungSilke Jennrich, Michael H Lee, Rachel C Lynn, et al.
Journal of Translational Medicine|December 16, 2014
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cellsKatarzyna Urbanska, Rachel C Lynn, Caitlin Stashwick, et al.
Blood|April 19, 2015
Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cellsRachel C Lynn, Mathilde Poussin, Anna Kalota, et al.
Oncoimmunology|February 6, 2018
Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccinesEdmund K Moon, Liang-Chuan S Wang, Kheng Bekdache, et al.
Cancer Research|February 9, 2012
A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptorKatarzyna Urbanska, Evripidis Lanitis, Mathilde Poussin, et al.
Molecular Brain|November 5, 2011
Regulation of chemotropic guidance of nerve growth cones by microRNALiang Han, Zhexing Wen, Rachel C Lynn, et al.
Nature Communications|February 10, 2021
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapyAlba Rodriguez-Garcia, Rachel C Lynn, Mathilde Poussin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2011
Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicityLiang-Chuan S Wang, Rachel C Lynn, Guanjun Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2021
Dynamic chromatin regulatory landscape of human CAR T cell exhaustionDavid G Gennert, Rachel C Lynn, Jeff M Granja, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cell|October 30, 2020
Strength in Numbers: Identifying Neoantigen Targets for Cancer ImmunotherapyRigel J Kishton, Rachel C Lynn, Nicholas P Restifo
Journal of Virology|January 27, 2012
Tissue exit: a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza a virus-infected lungSilke Jennrich, Michael H Lee, Rachel C Lynn, et al.
Journal of Translational Medicine|December 16, 2014
Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cellsKatarzyna Urbanska, Rachel C Lynn, Caitlin Stashwick, et al.
Blood|April 19, 2015
Targeting of folate receptor β on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cellsRachel C Lynn, Mathilde Poussin, Anna Kalota, et al.
Oncoimmunology|February 6, 2018
Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccinesEdmund K Moon, Liang-Chuan S Wang, Kheng Bekdache, et al.
Cancer Research|February 9, 2012
A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptorKatarzyna Urbanska, Evripidis Lanitis, Mathilde Poussin, et al.
Molecular Brain|November 5, 2011
Regulation of chemotropic guidance of nerve growth cones by microRNALiang Han, Zhexing Wen, Rachel C Lynn, et al.
Nature Communications|February 10, 2021
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapyAlba Rodriguez-Garcia, Rachel C Lynn, Mathilde Poussin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2011
Treating tumors with a vaccinia virus expressing IFNβ illustrates the complex relationships between oncolytic ability and immunogenicityLiang-Chuan S Wang, Rachel C Lynn, Guanjun Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2021
Dynamic chromatin regulatory landscape of human CAR T cell exhaustionDavid G Gennert, Rachel C Lynn, Jeff M Granja, et al.
Pageof 2